Tardive Dyskinesia Risks and Metoclopramide Use Before and After U.S. Market Withdrawal of Cisapride

Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia

S. Browne, Mark J. Roe, Abbie Lane et al. · Acta Psychiatrica Scandinavica · 1996 · 333 citations

Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age

James M. Smith · Archives of General Psychiatry · 1980 · 315 citations

Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems

David A. Kessler · JAMA · 1993 · 270 citations

Adverse Drug Reaction, New Drug Application, Preventive Medicine +19

The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders

Linda Ganzini · Archives of Internal Medicine · 1993 · 262 citations

Extrapyramidal reactions with metoclopramide.

D. Nicholas Bateman, M. D. Rawlins, Judy M. Simpson · BMJ · 1985 · 224 citations · Full text

Drug Safety, Medicinal Chemistry, Extrapyramidal Reactions +14